Newsletter Newsletters Events Events Podcasts Videos Africanews
Loader
Latest
Trending
Latest stories
Europe
Categories
Programmes
Featured
World
Categories
Programmes
Featured
EU Policy
Business
Categories
Programmes
Featured
Travel
Categories
Programmes
Next
Categories
Programmes
Featured
Culture
Categories
Programmes
Green
Categories
Programmes
Featured
Health
Categories
Programmes
Euroviews
Videos
More
Special coverage
Partner content
Services
Newsletter Newsletters Events Events Podcasts Videos Africanews
Loader
Find Us
Flipboard Instagram Linkedin
Advertisement

Germany says production capacity, not patents, key to upping vaccine output

Germany says production capacity, not patents, key to upping vaccine output
Germany says production capacity, not patents, key to upping vaccine output -  Copyright  (c) Copyright Thomson Reuters 2021. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Copyright (c) Copyright Thomson Reuters 2021. Click For Restrictions - https://agency.reuters.com/en/copyright.html
By Reuters
Published on
Share Comments
Share Close Button

BERLIN (Reuters) - The main challenge to raising production of COVID-19 vaccines is how to quickly and effectively transfer technology, Germany's health minister said Friday, reiterating Berlin's opposition to a U.S. proposal to waive patent protection.

ADVERTISEMENT
ADVERTISEMENT

"The main issue is not patent protection but production capacity," Jens Spahn told a news conference on Friday.

In a jab at the Biden administration, Spahn also said: "I would be delighted if the United States shows the same willingness to export vaccines that we in Germany do."

(Reporting by Douglas Busvine and Paul Carrel, editing by Riham Alkousaa)

Go to accessibility shortcuts
Share Comments

Read more

Teenage daughter of North Korean leader Kim Jong-un drives tank at military drill

Watch: Missile lands near Russian TV crew during live report in Lebanon

French hotel group Accor launches probe into allegations of child trafficking in Ukraine